Skip to content

Tumor Scintigraphy (Spot) Dual Phase Hyderabad | Focus Diagnostics

TUMOR SCINTIGRAPHY (SPOT) DUAL PHASE

Get reliable diagnostics, expert support, and a seamless booking experience with Focus Diagnostics.

PriceRs. 8200
Book Now

About this test

What is a Tumor Scintigraphy (Spot) Dual Phase Scan?

Tumor Scintigraphy (Spot) Dual Phase is a specialised nuclear medicine imaging investigation used to evaluate a selected region of the body for abnormal radiotracer uptake. The examination involves administering a suitable radioactive tracer and capturing images using a gamma camera at two different phases or time points. These images help assess the distribution, concentration and changes in tracer uptake within the targeted area. The choice of radiotracer depends on the suspected tumour type, clinical indication and nuclear medicine protocol. Unlike conventional anatomical imaging, scintigraphy provides functional information about tracer distribution in tissues. The investigation may help doctors assess selected tumour-related abnormalities and correlate functional imaging findings with other diagnostic examinations.

Why is Tumor Scintigraphy Dual Phase recommended?

A doctor may recommend Tumor Scintigraphy Dual Phase when additional functional imaging information is required to investigate a suspected tumour or an abnormality identified through other examinations. The dual-phase approach allows images to be compared at different acquisition times, helping specialists evaluate tracer uptake and retention patterns. Depending on the clinical indication and tracer used, the investigation may contribute to the assessment of selected tumour-related lesions, abnormal tissue activity and suspected areas requiring further evaluation. The scan is generally requested as part of a broader diagnostic assessment rather than as a standalone cancer diagnosis.

What conditions can Tumor Scintigraphy help evaluate?

Tumor scintigraphy may support the investigation of selected suspected neoplastic lesions, abnormal tissue activity and tumour-related abnormalities, depending on the radiotracer and imaging protocol. It may be requested when conventional imaging or clinical findings require additional functional information. The areas evaluated and the clinical usefulness of the scan vary according to the type of suspected tumour and the tracer selected. Abnormal tracer uptake does not necessarily indicate cancer because inflammatory, infectious and other non-malignant conditions may also produce abnormal imaging patterns. Findings must be interpreted alongside clinical history, laboratory investigations, ultrasound, CT, MRI or biopsy results where appropriate.

How is a Tumor Scintigraphy (Spot) Dual Phase Scan performed?

The investigation is performed in a nuclear medicine department using a gamma camera. A suitable radioactive tracer is administered according to the clinical indication and department protocol. After administration, the patient is positioned appropriately so that the required body region can be imaged. Initial images are acquired during the first phase, followed by additional images at a specified later time during the second phase. The comparison of both sets of images helps assess tracer distribution and changes in uptake or retention over time. The nuclear medicine specialist reviews the images and prepares a report based on the findings and clinical information supplied by the referring doctor.

Preparation before a Tumor Scintigraphy Scan

Preparation requirements depend on the radioactive tracer selected, the body region being examined and the patient's medical history. Fasting may or may not be required depending on the specific imaging protocol. Patients should inform the nuclear medicine team about current medications, previous nuclear medicine examinations, recent contrast imaging, allergies and relevant medical conditions. Pregnancy or breastfeeding must be reported before administration of any radioactive tracer. Patients should follow the specific instructions provided by the diagnostic centre regarding food, fluids, medication and arrival time. Do not discontinue prescribed medication without medical advice.

Understanding the Tumor Scintigraphy Dual Phase Report

The report describes the distribution and intensity of tracer uptake in the selected body region during the different imaging phases. It may include observations about focal or diffuse uptake, changes in tracer retention and any abnormal areas requiring clinical correlation. The interpretation depends on the radiotracer used, the acquisition timing, the suspected condition and the patient's clinical history. Increased or persistent tracer uptake does not automatically confirm a tumour or malignancy. Similarly, the absence of abnormal uptake does not exclude every type of tumour. The findings should be correlated with anatomical imaging, laboratory investigations and histopathological examination when clinically indicated.

Benefits of Tumor Scintigraphy (Spot) Dual Phase

Tumor Scintigraphy Dual Phase provides functional imaging information that may complement conventional diagnostic examinations. The comparison of images obtained at different time points helps specialists assess tracer uptake and retention patterns. The examination focuses on a selected body region according to the clinical requirement and uses gamma camera technology to capture radiotracer distribution. It may provide additional diagnostic information when evaluating selected tumour-related abnormalities and assist doctors in deciding whether further investigations are necessary.

Who may need a Tumor Scintigraphy Dual Phase Scan?

This investigation may be recommended for patients who require further evaluation of a suspected tumour-related abnormality or a lesion identified through other imaging examinations. It may be considered when a treating specialist or nuclear medicine physician believes that functional imaging could provide useful additional information. The decision depends on the suspected tumour type, clinical findings, previous investigation results and the availability of an appropriate radiotracer protocol. Not every tumour or cancer requires scintigraphy.

Is Tumor Scintigraphy safe?

Tumor scintigraphy involves the administration of a controlled quantity of radioactive tracer for diagnostic imaging. The radiation exposure is managed according to established nuclear medicine safety protocols. The amount and type of tracer depend on the examination protocol and clinical indication. Patients should inform the medical team about pregnancy, breastfeeding, allergies and existing medical conditions before the investigation. The nuclear medicine specialist will provide appropriate instructions and radiation safety guidance based on the patient's individual circumstances.

Difference between Single Phase and Dual Phase Scintigraphy

Single-phase scintigraphy generally involves acquiring images at one specified time point after radiotracer administration. Dual-phase scintigraphy involves acquiring images during two different phases or time points. Comparing these images can provide additional information about changes in tracer uptake and retention within the targeted region. The clinical value of dual-phase imaging depends on the tracer, suspected condition and imaging protocol selected by the nuclear medicine specialist.

Tumor Scintigraphy (Spot) Dual Phase at Focus Diagnostics, Hyderabad

Focus Diagnostics provides diagnostic imaging and nuclear medicine services in Hyderabad, Telangana. Tumor Scintigraphy (Spot) Dual Phase uses gamma camera technology to assess radiotracer distribution and uptake patterns in a selected body region. The investigation may support the evaluation of selected tumour-related abnormalities when recommended by a treating specialist. If your doctor has advised this scan, contact Focus Diagnostics to confirm the available tracer protocol, scan availability, preparation requirements, appointment details and expected reporting time.

Test FAQs

What is Tumor Scintigraphy (Spot) Dual Phase?

It is a nuclear medicine investigation that uses a radioactive tracer and gamma camera imaging to evaluate tracer distribution in a selected body region at two different imaging phases.

Why is a Tumor Scintigraphy Dual Phase Scan recommended?

It may be recommended when additional functional imaging information is needed to investigate a suspected tumour-related abnormality or an unusual finding on previous imaging.

What does a Tumor Scintigraphy Scan detect?

It evaluates radiotracer uptake and distribution in the targeted body region. The findings may help investigate selected tumour-related abnormalities depending on the tracer and clinical indication.

What is the meaning of dual phase imaging?

Dual phase imaging means acquiring images at two different time points after tracer administration to compare uptake and retention patterns.

Which radioactive tracer is used for Tumor Scintigraphy?

The tracer depends on the suspected tumour type and clinical indication. The nuclear medicine specialist selects the appropriate radiopharmaceutical and imaging protocol.

Is fasting required before a Tumor Scintigraphy Scan?

Preparation requirements depend on the tracer and examination protocol. Follow the specific instructions provided by the nuclear medicine department.

How is a Tumor Scintigraphy Dual Phase Scan performed?

A suitable radioactive tracer is administered, followed by gamma camera imaging during two different phases to evaluate tracer distribution and retention.

Can Tumor Scintigraphy confirm cancer?

No. Abnormal tracer uptake does not independently confirm cancer. Findings require correlation with clinical information, other imaging examinations and biopsy when indicated.

Is Tumor Scintigraphy safe?

It is a diagnostic nuclear medicine procedure using a controlled quantity of radioactive tracer. Inform the medical team about pregnancy or breastfeeding before the examination.

What is the difference between a CT scan and Tumor Scintigraphy?

CT provides detailed anatomical images of body structures, whereas tumor scintigraphy evaluates functional radiotracer uptake and distribution. Both examinations may provide complementary information.

Where can I get a Tumor Scintigraphy Dual Phase Scan in Hyderabad?

You can contact Focus Diagnostics, Hyderabad, to enquire about scan availability, the required tracer protocol, appointment scheduling and preparation instructions.

TUMOR SCINTIGRAPHY (SPOT) DUAL PHASE

Rs. 8200

Book

Where this gamma camera scan is done in Hyderabad

All nuclear medicine tests and prices in Hyderabad

Explore Related Tests & Services

Find Your Nearest Focus Diagnostic Centre Hyderabad

Popular Lab Tests in Other Cities

Book Your lab tests instantly

Accurate reports and home sample collection across Hyderabad

Book on Whatsapp